BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 29242302)

  • 1. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
    Kawamoto K; Miyoshi H; Suzuki T; Kozai Y; Kato K; Miyahara M; Yujiri T; Choi I; Fujimaki K; Muta T; Kume M; Moriguchi S; Tamura S; Kato T; Tagawa H; Makiyama J; Kanisawa Y; Sasaki Y; Kurita D; Yamada K; Shimono J; Sone H; Takizawa J; Seto M; Kimura H; Ohshima K
    Haematologica; 2018 Jun; 103(6):1018-1028. PubMed ID: 29242302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
    Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S
    Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
    Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
    J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
    Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
    [No Abstract]   [Full Text] [Related]  

  • 13. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
    Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
    Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system vasculitis from Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children: A case report.
    Lee MS; Hwang SK; Kim YE; Suh JK; Kim H; Lee SM; Jeong JY; Kwon S; Lee YJ
    Brain Dev; 2019 Oct; 41(9):820-825. PubMed ID: 31208818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population.
    Murga-Zamalloa C; Stone MB; Gutierrez MG; Hippalgaonkar NR; Tariq H; Sadeh M; Mehta A; Khan I; Alkan S; Inamdar KV; Wilcox R; Behdad A
    Am J Clin Pathol; 2024 Jun; 161(6):586-597. PubMed ID: 38345307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children.
    Xu Z; Lian S
    Pediatr Dermatol; 2010; 27(5):463-9. PubMed ID: 20497358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
    Cai Q; Chen K; Young KH
    Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
    Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
    BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting.
    Cohen JI; Iwatsuki K; Ko YH; Kimura H; Manoli I; Ohshima K; Pittaluga S; Quintanilla-Martinez L; Jaffe ES
    Leuk Lymphoma; 2020 Apr; 61(4):808-819. PubMed ID: 31833428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.